1. Home
  2. OPAD vs GANX Comparison

OPAD vs GANX Comparison

Compare OPAD & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPAD
  • GANX
  • Stock Information
  • Founded
  • OPAD 2015
  • GANX 2017
  • Country
  • OPAD United States
  • GANX United States
  • Employees
  • OPAD N/A
  • GANX N/A
  • Industry
  • OPAD Real Estate
  • GANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • OPAD Finance
  • GANX Health Care
  • Exchange
  • OPAD Nasdaq
  • GANX Nasdaq
  • Market Cap
  • OPAD 89.3M
  • GANX 79.8M
  • IPO Year
  • OPAD N/A
  • GANX 2021
  • Fundamental
  • Price
  • OPAD $1.83
  • GANX $2.70
  • Analyst Decision
  • OPAD Hold
  • GANX Strong Buy
  • Analyst Count
  • OPAD 4
  • GANX 6
  • Target Price
  • OPAD $2.22
  • GANX $8.00
  • AVG Volume (30 Days)
  • OPAD 1.8M
  • GANX 1.1M
  • Earning Date
  • OPAD 11-03-2025
  • GANX 11-12-2025
  • Dividend Yield
  • OPAD N/A
  • GANX N/A
  • EPS Growth
  • OPAD N/A
  • GANX N/A
  • EPS
  • OPAD N/A
  • GANX N/A
  • Revenue
  • OPAD $627,966,000.00
  • GANX N/A
  • Revenue This Year
  • OPAD N/A
  • GANX N/A
  • Revenue Next Year
  • OPAD $31.90
  • GANX N/A
  • P/E Ratio
  • OPAD N/A
  • GANX N/A
  • Revenue Growth
  • OPAD N/A
  • GANX N/A
  • 52 Week Low
  • OPAD $0.91
  • GANX $1.41
  • 52 Week High
  • OPAD $6.35
  • GANX $3.06
  • Technical
  • Relative Strength Index (RSI)
  • OPAD 37.80
  • GANX 65.86
  • Support Level
  • OPAD $1.64
  • GANX $2.53
  • Resistance Level
  • OPAD $2.19
  • GANX $3.06
  • Average True Range (ATR)
  • OPAD 0.19
  • GANX 0.26
  • MACD
  • OPAD 0.02
  • GANX 0.09
  • Stochastic Oscillator
  • OPAD 29.13
  • GANX 77.86

About OPAD Offerpad Solutions Inc.

Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

Share on Social Networks: